These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 38240103)
21. CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer. Zhang Y; Zang M; Li J; Ji J; Zhang J; Liu X; Qu Y; Su L; Li C; Yu Y; Zhu Z; Liu B; Yan M Acta Biochim Biophys Sin (Shanghai); 2014 Apr; 46(4):283-90. PubMed ID: 24492534 [TBL] [Abstract][Full Text] [Related]
22. CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1. Yang T; Wang H; Li M; Yang L; Han Y; Liu C; Zhang B; Wu M; Wang G; Zhang Z; Zhang W; Huang J; Zhang H; Cao T; Chen P; Zhang W Int J Biol Sci; 2021; 17(3):848-860. PubMed ID: 33767593 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells. Lewis-Wambi JS; Cunliffe HE; Kim HR; Willis AL; Jordan VC Eur J Cancer; 2008 Aug; 44(12):1770-9. PubMed ID: 18614350 [TBL] [Abstract][Full Text] [Related]
24. Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells. Iwabuchi E; Miki Y; Onodera Y; Shibahara Y; Takagi K; Suzuki T; Ishida T; Sasano H Clin Exp Metastasis; 2019 Oct; 36(5):423-432. PubMed ID: 31222613 [TBL] [Abstract][Full Text] [Related]
26. CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling. Han SU; Kwak TH; Her KH; Cho YH; Choi C; Lee HJ; Hong S; Park YS; Kim YS; Kim TA; Kim SJ Oncogene; 2008 Jan; 27(5):675-83. PubMed ID: 17653079 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity. Hong KP; Shin MH; Yoon S; Ji GY; Moon YR; Lee OJ; Choi SY; Lee YM; Koo JH; Lee HC; Lee GK; Kim SR; Lee KH; Han HS; Choe KH; Lee KM; Hong JM; Kim SW; Yi JH; Ji HJ; Kim YB; Song HG Biomaterials; 2015 Oct; 67():32-41. PubMed ID: 26204223 [TBL] [Abstract][Full Text] [Related]
28. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Duxbury MS; Ito H; Benoit E; Ashley SW; Whang EE Br J Cancer; 2004 Oct; 91(7):1384-90. PubMed ID: 15316565 [TBL] [Abstract][Full Text] [Related]
29. GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction. Ordonez C; Zhai AB; Camacho-Leal P; Demarte L; Fan MM; Stanners CP J Cell Physiol; 2007 Mar; 210(3):757-65. PubMed ID: 17167768 [TBL] [Abstract][Full Text] [Related]
30. Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis. Cameron S; de Long LM; Hazar-Rethinam M; Topkas E; Endo-Munoz L; Cumming A; Gannon O; Guminski A; Saunders N Mol Cancer; 2012 Sep; 11():74. PubMed ID: 23021083 [TBL] [Abstract][Full Text] [Related]
31. Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers. Tsang JY; Kwok YK; Chan KW; Ni YB; Chow WN; Lau KF; Shao MM; Chan SK; Tan PH; Tse GM Breast Cancer Res Treat; 2013 Nov; 142(2):311-22. PubMed ID: 24186057 [TBL] [Abstract][Full Text] [Related]
32. Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma. Deng X; Liu P; Zhao Y; Wang Q Genet Mol Res; 2014 Sep; 13(3):7686-97. PubMed ID: 25299082 [TBL] [Abstract][Full Text] [Related]
33. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Ilantzis C; DeMarte L; Screaton RA; Stanners CP Neoplasia; 2002; 4(2):151-63. PubMed ID: 11896570 [TBL] [Abstract][Full Text] [Related]
34. CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma. Wang X; Tang X; Gu J; Sun Z; Yang S; Mu Y; Guan M; Chen K; Liu W; Ruan H; Xu J Cancer Med; 2023 Feb; 12(4):4521-4529. PubMed ID: 36082960 [TBL] [Abstract][Full Text] [Related]
35. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components. Duxbury MS; Ito H; Ashley SW; Whang EE Biochem Biophys Res Commun; 2004 Apr; 317(1):133-41. PubMed ID: 15047158 [TBL] [Abstract][Full Text] [Related]
36. CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. Wang Y; Gangeswaran R; Zhao X; Wang P; Tysome J; Bhakta V; Yuan M; Chikkanna-Gowda CP; Jiang G; Gao D; Cao F; Francis J; Yu J; Liu K; Yang H; Zhang Y; Zang W; Chelala C; Dong Z; Lemoine N J Clin Invest; 2009 Jun; 119(6):1604-15. PubMed ID: 19411761 [TBL] [Abstract][Full Text] [Related]
37. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794 [TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. Gebauer F; Wicklein D; Horst J; Sundermann P; Maar H; Streichert T; Tachezy M; Izbicki JR; Bockhorn M; Schumacher U PLoS One; 2014; 9(11):e113023. PubMed ID: 25409014 [TBL] [Abstract][Full Text] [Related]
39. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Beauchemin N; Arabzadeh A Cancer Metastasis Rev; 2013 Dec; 32(3-4):643-71. PubMed ID: 23903773 [TBL] [Abstract][Full Text] [Related]
40. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]